Skip to main content
Scope Fluidics S.A. logo

Scope Fluidics S.A. — Investor Relations & Filings

Ticker · SCP ISIN · PLSCPFL00018 LEI · 259400EUNFX4E2BEHU15 WAR Professional, scientific and technical activities
Open in API
Filings indexed 510 across all filing types
Latest filing 2019-12-10 Major Shareholding Noti…
Country PL Poland
Listing WAR SCP

About Scope Fluidics S.A.

https://scopefluidics.com/

Scope Fluidics S.A. is a biotechnology company that develops innovative medical diagnostic solutions based on microfluidic technologies. The company's business model involves incubating projects within special-purpose vehicles (SPVs) with the goal of selling them to global strategic partners. Its primary project, developed by its subsidiary Bacteromic Sp. z o.o., is the BACTEROMIC system. This automated system provides rapid, comprehensive antimicrobial susceptibility testing (AST) to address the challenge of antibiotic resistance. Previously, the company developed the PCR|ONE system for rapid molecular diagnostics through its Curiosity Diagnostics SPV, which was acquired by Bio-Rad in 2022. The company focuses on creating fast, effective, and accessible diagnostic tools to improve healthcare outcomes.

Recent filings

Filing Released Lang Actions
Rozpoczęcie procesu budowania przyśpieszonej książki popytu (ABB) przez akcjonariusza Spółki. - Content (PL)
Major Shareholding Notification Classification · 1% confidence The document text discusses a shareholder, TOTAL FIZ, initiating an accelerated book-building process (ABB) to sell up to 170,772 shares of Scope Fluidics S.A. This action is related to a placement agreement and involves the offering and sale of existing shares, referencing exemptions from prospectus requirements under EU regulations. This clearly falls under the category of changes in significant share ownership or transactions involving the company's capital structure initiated by a major shareholder, which aligns best with 'Major Shareholding Notification' (MRQ) or potentially 'Share Issue/Capital Change' (SHA). Since the focus is on a major shareholder selling a significant block of shares (7.37%), MRQ is the most precise fit for reporting changes in significant ownership thresholds, even though it's an active sale announcement. Given the context of a major shareholder selling a large block of shares, MRQ is the most appropriate classification.
2019-12-10 Polish
Zawarcie przez Spółkę z TOTAL FIZ i mBank S.A. umowy plasowania akcji w ramach procesu ABB - Content (PL)
Share Issue/Capital Change Classification · 1% confidence The document details an agreement (Umowa Plasowania) for the placement and sale of existing shares (Akcje Oferowane) by a major shareholder (Sprzedający) to selected investors, involving a price range (up to 70 PLN) and referencing EU Prospectus Regulation (Rozporządzenie Prospektowe). It also mentions a concurrent resolution by the General Meeting regarding a capital increase via a private subscription (subskrypcji prywatnej) to ensure the seller maintains a specific voting stake (26.25%). The text explicitly states it is a current report prepared to fulfill the disclosure obligation under Article 17(1) of the Market Abuse Regulation (MAR). This type of announcement, concerning the sale of existing shares by an insider/major shareholder and related capital structure changes, falls under corporate actions related to financing or share transactions. Since it describes a specific transaction involving the sale of existing shares by an insider/major shareholder, 'Transaction in Own Shares' (POS) is a possibility if the company were the seller, but here it's a major shareholder selling. However, the core event is a significant transaction affecting capital structure and ownership, often categorized under financing activities or major shareholding changes. Given the context of a major shareholder selling a large block of shares (up to 7.37%) and the concurrent capital increase resolution, this is fundamentally a capital/financing activity announcement. 'CAP' (Capital/Financing Update) is the most appropriate fit for significant share placement/sale agreements that impact capital structure, even if initiated by a shareholder, especially when tied to a new share issuance resolution. It is not a standard 10-K, ER, or IR. It is a specific disclosure, not just a general regulatory filing (RNS) or a report announcement (RPA).
2019-12-10 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% na NWZA w dniu 10.12.2019
AGM Information Classification · 1% confidence The document text is in Polish and presents a list ('Wykaz akcjonariuszy') detailing shareholders who hold at least 5% of the votes at an Extraordinary General Meeting ('Nadzwyczajnym Walnym Zgromadzeniu') held on December 10, 2019. It lists the shareholder name, number of shares, number of votes, and percentage of votes/shares at the meeting and in total. This content directly relates to the official results of a shareholder vote at a general meeting. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and contains the results themselves, not an announcement about the results being published.
2019-12-10 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym Walnym Zgromadzeniu Spółki, które odbyło się w dniu 10 grudnia 2019 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is in Polish and discusses the list of shareholders holding at least 5% of the votes at an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie) held on December 10, 2019. This content directly relates to the results or details of a shareholder vote at a general meeting. The most fitting category is 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it details the voting power distribution among major shareholders following a meeting.
2019-12-10 Polish
Powiadomienie o transakcjach - Kamil Gewartowski - kierownik projektu PCR|ONE
Director's Dealing Classification · 1% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction made by a person discharging managerial responsibilities ('Kamil Gewartowski') involving the purchase ('Kupno') of company shares ('AKCIE') of Scope Fluidics SA. This structure and content directly correspond to insider trading reports required under MAR (Market Abuse Regulation), which specifically track transactions by directors and executives. This matches the definition for Director's Dealing (DIRS).
2019-12-04 Polish
Otrzymanie zawiadomienia w trybie art. 19 ust. 3. MAR - transakcja nabycia akcji Emitenta przez Kierownika Projektu PCR|ONE - Content (PL)
Director's Dealing Classification · 1% confidence The document text is very short (453 characters) and explicitly states that it is transmitting an 'announcement' (zawiadomienie) made under Article 19(1) of Regulation (EU) No 596/2014 (MAR). This regulation concerns insider transactions (transactions by persons discharging managerial responsibilities). The text further specifies that the announcement concerns the acquisition of shares by Mr. Kamil Gewartowski, a Project Manager. This directly corresponds to the definition of Director's Dealing (insider trades by executives/managers). The filing type code for this is DIRS.
2019-12-04 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.